.pf{position:relative;background-color:#fff;overflow:hidden;margin:0;border:0}.pc{position:absolute;border:0;padding:0;margin:0;top:0;left:0;width:100%;height:100%;overflow:hidden;display:block;transform-origin:0 0;-ms-transform-origin:0 0;-webkit-transform-origin:0 0}.bi{position:absolute;border:0;margin:0}.t{position:absolute;white-space:pre;font-size:1px;transform-origin:0 100%;-ms-transform-origin:0 100%;-webkit-transform-origin:0 100%;unicode-bidi:bidi-override;-moz-font-feature-settings:"liga" 0}.t:after{content:''}.t:before{content:'';display:inline-block}.t span{position:relative;unicode-bidi:bidi-override}._{display:inline-block;color:transparent;z-index:-1}.pi{display:none}@media screen{.pf{margin:13px auto;box-shadow:1px 1px 3px 1px #333;border-collapse:separate}}.ff1{font-family:ff1;line-height:.925293;font-style:normal;font-weight:400;visibility:visible}.ff2{font-family:ff2;line-height:.919922;font-style:normal;font-weight:400;visibility:visible}@font-face{font-family:ff3;src:url(data:application/font-woff;base64,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) format("woff")}.ff3{font-family:ff3;line-height:.27;font-style:normal;font-weight:400;visibility:visible}@font-face{font-family:ff4;src:url(data:application/font-woff;base64,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) format("woff")}.ff4{font-family:ff4;line-height:.779297;font-style:normal;font-weight:400;visibility:visible}.m0{transform:matrix(.320260,0,0,.320260,0,0);-ms-transform:matrix(.320260,0,0,.320260,0,0);-webkit-transform:matrix(.320260,0,0,.320260,0,0)}.ls1{letter-spacing:0}.ls0{letter-spacing:55.2px}.sc0{text-shadow:-.015em 0 transparent,0 .015em transparent,.015em 0 transparent,0 -.015em transparent}@media screen and (-webkit-min-device-pixel-ratio:0){.sc0{-webkit-text-stroke:.015em transparent;text-shadow:none}}.ws0{word-spacing:-39.936px}.ws1{word-spacing:-31.248px}.ws2{word-spacing:0}._1{margin-left:-4.895651px}._3{margin-left:-2.832083px}._0{margin-left:-1.248365px}._2{width:1.060932px}.fc0{color:#000}.fs0{font-size:48px}.y0{bottom:10.888853px}.y1b{bottom:134.637469px}.y1a{bottom:152.700155px}.y19{bottom:170.762841px}.y18{bottom:188.825527px}.y17{bottom:206.888213px}.y16{bottom:225.719524px}.y15{bottom:243.78221px}.y14{bottom:262.741625px}.y13{bottom:281.572936px}.y12{bottom:299.635622px}.y11{bottom:558.662227px}.y10{bottom:595.684328px}.yf{bottom:613.747014px}.ye{bottom:632.578325px}.yd{bottom:650.641011px}.yc{bottom:669.600426px}.yb{bottom:688.431737px}.ya{bottom:707.391152px}.y9{bottom:726.222463px}.y8{bottom:745.181878px}.y7{bottom:763.244565px}.y6{bottom:799.369937px}.y5{bottom:817.432623px}.y4{bottom:835.495309px}.y3{bottom:853.557995px}.y2{bottom:871.620681px}.y1{bottom:907.746053px}.y1f{bottom:992.050117px}.h3{height:33.65625px}.h2{height:33.9375px}.h4{height:36.726562px}.h1{height:999.852942px}.h0{height:1014.58492px}.w1{width:621.94568px}.w0{width:783.997438px}.x0{left:24.33979px}.x1{left:115.421845px}.x2{left:138.480593px}.x4{left:467.074160px}

HSS 3106 Final: Pharm part 2

Canada

Pharmacology: Mechanisms and Compliance

Health Sciences

Ron Saulnier

University of Ottawa

Introduction to Cell Biology

Genetics

Human Anatomy and Physiology II

Pathophysiology of Health Problems

Development and Evaluation of Health Programs

Practical Nursing PNH301 Lecture Notes - Lecture 3: Role Theory, Etiology, Urinary Retention

PHAC 4001 Lecture Notes - Lecture 28: Multiple Sclerosis, Twin Study, Twin

EHR525 Lecture Notes - Lecture 12: Multiple Sclerosis, Demyelinating Disease, Spinal Cord

HSS 3106 Final: Pharm part 2

Get access

Related Documents

Practical Nursing PNH301 Lecture Notes - Lecture 3: Role Theory, Etiology, Urinary Retention

PHAC 4001 Lecture Notes - Lecture 28: Multiple Sclerosis, Twin Study, Twin

EHR525 Lecture Notes - Lecture 12: Multiple Sclerosis, Demyelinating Disease, Spinal Cord